InSightec: Clinical Trials

9 trials sponsored by InSightec, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting, 1 withdrawn. 9 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 6, Active not recruiting 2, Withdrawn 1
Phase 14Active not recruiting 2, Completed 2

Follow InSightec: new trials by email

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab - Recurrent Glioblastoma
Phase 2WithdrawnM.D. Anderson Cancer Center2024-07-302024-11-20
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
Exablate, Doxorubicin - Brain Tumor
Phase 1 / Phase 2Active not recruitingInSightec102023-01-042026-04-17
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG
Exablate, Doxorubicin - Brain Tumor
Phase 1 / Phase 2Active not recruitingInSightec102023-01-042026-04-21
Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
Carboplatin, Exablate BBBD - Recurrent Glioblastoma
Phase 1 / Phase 2CompletedInSightec282020-11-062026-03-20
Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
Exablate BBBD, Carboplatin - Recurrent Glioblastoma
Phase 1 / Phase 2CompletedInSightec132020-10-132026-01-20
Study of ExAblate Focused Ultrasound Ablation of Breast Cancer
ExAblate MRgFUS - Breast Cancer
Phase 2CompletedInSightec142010-11-242026-09-08
Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
ExAblate 2100 - Bone Cancer, Bone Metastases
Phase 2CompletedInSightec502010-03-012016-03-08
Safety and Efficacy of MRgFUS for the Treatment of Low Back Pain
Exablate treatment - Lower Back Pain, Facets Joints Osteoarthritis
Phase 2CompletedInSightec502009-10-012012-02-22
MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer
high-intensity focused ultrasound ablation - Breast Cancer
Phase 2CompletedInSightec2000-12-012012-07-02

Conditions studied

Breast Neoplasms (3)  ·  Glioblastoma (3)  ·  Brain Neoplasms (2)  ·  Bone Neoplasms (1)  ·  Cancer Pain (1)  ·  Disease (1)  ·  Low Back Pain (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pain (1)  ·  Prostatic Neoplasms (1)

Interventions

Carboplatin (2)  ·  Doxorubicin (2)  ·  High-Intensity Focused Ultrasound Ablation (1)  ·  pembrolizumab (1)

Countries

United States (4)  ·  Canada (3)  ·  Israel (2)  ·  Germany (1)  ·  Italy (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Hans Kolberg, MD (1)  ·  Robert W. Newman (1)  ·  Sagi Harnof, MD (1)  ·  Vinay Puduvalli, MD (1)